These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 6285172

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Selective inhibition of the proliferation of herpes simplex virus type 1 thymidine kinase gene-transformed murine mammary FM3A carcinoma cells by (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compounds.
    Balzarini J, De Clercq E, Ayusawa D, Shimizu K, Seno T.
    Nucleic Acids Symp Ser; 1985; (16):283-6. PubMed ID: 3003708
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU).
    De Clercq E.
    Med Res Rev; 2005 Jan; 25(1):1-20. PubMed ID: 15389733
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. (E)-5-(2-bromovinyl)-2'-deoxyuridine potentiates ganciclovir-mediated cytotoxicity on herpes simplex virus-thymidine kinase--expressing cells.
    Hamel W, Zirkel D, Mehdorn HM, Westphal M, Israel MA.
    Cancer Gene Ther; 2001 May; 8(5):388-96. PubMed ID: 11477459
    [Abstract] [Full Text] [Related]

  • 13. Differential affinities of 5-(2-halogenovinyl)-2'-deoxyuridines for deoxythymidine kinases of various origins.
    Cheng YC, Dutschman G, De Clercq E, Jones AS, Rahim SG, Verhelst G, Walker RT.
    Mol Pharmacol; 1981 Jul; 20(1):230-3. PubMed ID: 6270535
    [No Abstract] [Full Text] [Related]

  • 14. (E)-5-(2-bromovinyl)uridine requires phosphorylation by the herpes simplex virus (type 1)-induced thymidine kinase to express its antiviral activity.
    Bernaerts R, Desgranges C, De Clercq E.
    Biochem Pharmacol; 1989 Jun 15; 38(12):1955-61. PubMed ID: 2545207
    [Abstract] [Full Text] [Related]

  • 15. Preferential inhibition of 5-trifluoromethyl-2'-deoxyuridine phosphorylation by 5'-amino-5'-deoxythymidine in uninfected versus herpes simplex virus-infected cells.
    Fischer PH, Murphy DG, Kawahara R.
    Mol Pharmacol; 1983 Jul 15; 24(1):90-6. PubMed ID: 6408395
    [Abstract] [Full Text] [Related]

  • 16. Incorporation of (E)-5-(2-iodovinyl)-2'-deoxyuridine into deoxyribonucleic acids of varicella-zoster virus (TK+ and TK- strains)-infected cells.
    Yokota T, Konno K, Shigeta S, Verbruggen A, De Clercq E.
    Mol Pharmacol; 1987 May 15; 31(5):493-9. PubMed ID: 3033468
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Differential binding affinities of sugar-modified derivatives of (E)-5-(2-bromovinyl)-2'-deoxyuridine for herpes simplex virus-induced and human cellular deoxythymidine kinases.
    Zou FC, Dutschman GE, De Clercq E, Cheng YC.
    Biochem Pharmacol; 1984 Jun 01; 33(11):1797-800. PubMed ID: 6329218
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.